+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Zoledronic Acid"

From
Osteoporosis Drugs Market Report 2025 - Product Thumbnail Image

Osteoporosis Drugs Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Osteoporosis Treatment Market Report 2025 - Product Thumbnail Image

Osteoporosis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Postmenopausal Osteoporosis Treatment Market Report 2025 - Product Thumbnail Image

Postmenopausal Osteoporosis Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Postmenopausal Osteoporosis - Pipeline Insight, 2025 - Product Thumbnail Image

Postmenopausal Osteoporosis - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
  • 10 Results (Page 1 of 1)
Loading Indicator

Zoledronic acid is a drug used to treat endocrine and metabolic disorders. It is a bisphosphonate, a type of drug that helps to reduce the activity of cells that break down bone. Zoledronic acid is used to treat conditions such as osteoporosis, Paget's disease, and hypercalcemia. It is also used to reduce the risk of fractures in people with osteoporosis. Zoledronic acid works by slowing down the activity of cells that break down bone, which helps to reduce bone loss and increase bone density. Zoledronic acid is available in both oral and intravenous forms. The intravenous form is usually given as an infusion over a period of 15 minutes. The oral form is taken as a tablet once a day. Common side effects of zoledronic acid include nausea, vomiting, and diarrhea. Companies in the zoledronic acid market include Novartis, Amgen, Merck, and Teva Pharmaceuticals. Show Less Read more